[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti Obesity Drugs Market Research Report 2016

November 2016 | 110 pages | ID: G7725DF49D2EN
QYResearch

US$ 2,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Production, means the output of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies Anti Obesity Drugs in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering
  • Pfizer
  • Merck
  • Roche
  • GlaxoSmithKline
  • AstraZeneca
  • Boehringer Ingelheim
  • Novo Nordisk
  • Eisai
  • Norgine
  • Arena Pharmaceuticals
  • Orexigen Therapeutics
  • Vivus
  • Alizyme
  • Rhythm Pharmaceuticals
  • Shionogi
  • Zafgan
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Anti Obesity Drugs in these regions, from 2011 to 2021 (forecast), like
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
  • Type I
  • Type II
  • Type III
Split by application, this report focuses on consumption, market share and growth rate of Anti Obesity Drugs in each application, can be divided into
  • Application 1
  • Application 2
  • Application 3
Global Anti Obesity Drugs Market Research Report 2016

1 ANTI OBESITY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Anti Obesity Drugs Segment by Type
  1.2.1 Global Production Market Share of Anti Obesity Drugs by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Anti Obesity Drugs Segment by Application
  1.3.1 Anti Obesity Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Anti Obesity Drugs Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Anti Obesity Drugs (2011-2021)

2 GLOBAL ANTI OBESITY DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Anti Obesity Drugs Production and Share by Manufacturers (2015 and 2016)
2.2 Global Anti Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Anti Obesity Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti Obesity Drugs Manufacturing Base Distribution, Sales Area and Product Type
2.5 Anti Obesity Drugs Market Competitive Situation and Trends
  2.5.1 Anti Obesity Drugs Market Concentration Rate
  2.5.2 Anti Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTI OBESITY DRUGS PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Anti Obesity Drugs Production and Market Share by Region (2011-2016)
3.2 Global Anti Obesity Drugs Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL ANTI OBESITY DRUGS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Anti Obesity Drugs Consumption by Regions (2011-2016)
4.2 North America Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Anti Obesity Drugs Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL ANTI OBESITY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Anti Obesity Drugs Production and Market Share by Type (2011-2016)
5.2 Global Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
5.3 Global Anti Obesity Drugs Price by Type (2011-2016)
5.4 Global Anti Obesity Drugs Production Growth by Type (2011-2016)

6 GLOBAL ANTI OBESITY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 Global Anti Obesity Drugs Consumption and Market Share by Application (2011-2016)
6.2 Global Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTI OBESITY DRUGS MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Anti Obesity Drugs Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Merck
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Anti Obesity Drugs Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Merck Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Roche
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Anti Obesity Drugs Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Roche Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 GlaxoSmithKline
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Anti Obesity Drugs Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 GlaxoSmithKline Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 AstraZeneca
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Anti Obesity Drugs Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 AstraZeneca Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Boehringer Ingelheim
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Anti Obesity Drugs Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Boehringer Ingelheim Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Anti Obesity Drugs Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Novo Nordisk Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Eisai
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Anti Obesity Drugs Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Eisai Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Norgine
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Anti Obesity Drugs Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 Norgine Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Arena Pharmaceuticals
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Anti Obesity Drugs Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Arena Pharmaceuticals Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Orexigen Therapeutics
7.12 Vivus
7.13 Alizyme
7.14 Rhythm Pharmaceuticals
7.15 Shionogi
7.16 Zafgan

8 ANTI OBESITY DRUGS MANUFACTURING COST ANALYSIS

8.1 Anti Obesity Drugs Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Anti Obesity Drugs

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Anti Obesity Drugs Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTI OBESITY DRUGS MARKET FORECAST (2016-2021)

12.1 Global Anti Obesity Drugs Production, Revenue Forecast (2016-2021)
12.2 Global Anti Obesity Drugs Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Anti Obesity Drugs Production Forecast by Type (2016-2021)
12.4 Global Anti Obesity Drugs Consumption Forecast by Application (2016-2021)
12.5 Anti Obesity Drugs Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Figure Global Production Market Share of Anti Obesity Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Anti Obesity Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Anti Obesity Drugs Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Anti Obesity Drugs Production of Key Manufacturers (2015 and 2016)
Table Global Anti Obesity Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti Obesity Drugs Production Share by Manufacturers
Figure 2016 Anti Obesity Drugs Production Share by Manufacturers
Table Global Anti Obesity Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 Global Anti Obesity Drugs Revenue Share by Manufacturers
Table Global Market Anti Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Anti Obesity Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Anti Obesity Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti Obesity Drugs Product Type
Figure Anti Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti Obesity Drugs Market Share of Top 5 Manufacturers
Table Global Anti Obesity Drugs Production by Regions (2011-2016)
Figure Global Anti Obesity Drugs Production and Market Share by Regions (2011-2016)
Figure Global Anti Obesity Drugs Production Market Share by Regions (2011-2016)
Figure 2015 Global Anti Obesity Drugs Production Market Share by Regions
Table Global Anti Obesity Drugs Revenue by Regions (2011-2016)
Table Global Anti Obesity Drugs Revenue Market Share by Regions (2011-2016)
Table 2015 Global Anti Obesity Drugs Revenue Market Share by Regions
Table Global Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table China Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table India Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Anti Obesity Drugs Consumption Market by Regions (2011-2016)
Table Global Anti Obesity Drugs Consumption Market Share by Regions (2011-2016)
Figure Global Anti Obesity Drugs Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Anti Obesity Drugs Consumption Market Share by Regions
Table North America Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table Europe Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table China Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table Japan Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table India Anti Obesity Drugs Production, Consumption, Import & Export (2011-2016)
Table Global Anti Obesity Drugs Production by Type (2011-2016)
Table Global Anti Obesity Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Anti Obesity Drugs by Type
Table Global Anti Obesity Drugs Revenue by Type (2011-2016)
Table Global Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Anti Obesity Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Anti Obesity Drugs by Type
Table Global Anti Obesity Drugs Price by Type (2011-2016)
Figure Global Anti Obesity Drugs Production Growth by Type (2011-2016)
Table Global Anti Obesity Drugs Consumption by Application (2011-2016)
Table Global Anti Obesity Drugs Consumption Market Share by Application (2011-2016)
Figure Global Anti Obesity Drugs Consumption Market Share by Application in 2015
Table Global Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
Figure Global Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Anti Obesity Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Anti Obesity Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Anti Obesity Drugs Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Anti Obesity Drugs Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Anti Obesity Drugs Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Anti Obesity Drugs Market Share (2011-2016)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Anti Obesity Drugs Market Share (2011-2016)
Table Norgine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Norgine Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Norgine Anti Obesity Drugs Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Anti Obesity Drugs Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals Anti Obesity Drugs Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure Global Anti Obesity Drugs Production and Growth Rate Forecast (2016-2021)
Figure Global Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Global Anti Obesity Drugs Production Forecast by Regions (2016-2021)
Table Global Anti Obesity Drugs Consumption Forecast by Regions (2016-2021)
Table Global Anti Obesity Drugs Production Forecast by Type (2016-2021)
Table Global Anti Obesity Drugs Consumption Forecast by Application (2016-2021)


More Publications